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m978149 Angiotensin II Receptor Antagonist Enhsnces theEffects of Angiotenein Converting Enzyme
inhibitor in Conscious Pigs with Congestive Hesrt
Fsilure
Y.-T.Shen, J.J. Lynch, R.T.Wiedmann, B.D. Greenland, W. Grossman.
Merck Research Laboratories, West Point, PA, USA
Ithas been auggested that angiotensin II (All) is not generated exclusively
via the angiotensin converting enzyme (ACE) pathway. The goal of this
atudy was to determine if the addition of All receptor block enhances the
efficacy of an ACE inhibitor (ACEI) during hearf failure development. To
accomplish this, 5 pigs were instrumented with catheters, Ieftventricular (LV)
pressure gaugea, dimension ctyatals, coronary occluders, aorticflow probes
and pacers. Hearl failure, induced by serial myoeerdial infarctions followed
by intermittent tachyoerdiac stress, was manifested by significant decreases
in LVdP/dt (–43 +8% from 2874+ 106 mmHg/see) and cardiac index (–35
+5% from 127 + 7 ml/min/kg) and increases in left atrial pressure (+18+2
mmHg from 4 + 1 mmHg) and total peripheral resistance (TPR) (+52 + 12%
from 0.72 + 0.06 units). ACEI (Enalaprflat, 1 mg/kg iv.) reduced TPR by 14
& 2 and 104=3% at 15 and 60 min after injection, while fractional shortening
and Vef were slightly increased and LVdP/dt and heart rate were unchanged.
ACEI (1 mgkg) followed by All block (L-158,809, 1 m~kg), administered 30
min apart, reduced TPR by 20 + 4% at 60 min after the initial injection.
However, ACEI followed by a 2nd dose of ACEI (1 mg/kg) reduced TPR (–8
i 3%) less (p < 0.05) at 60 min than did ACEI with All block. Furthermore,
higher doses (4 mg/kg) of either ACEI or All block induced similar peak
reductions in TPR (ACEI: -15 + 4Yo; All block: –17 + 47.). These changes
were less than both agents (1 mg/kg each) administered together (-24 +
4%). These results suggest that in mnscious pigs during heart failure, All
receptor block enhances the reduction of peripheral vasoeonstrietion induced
by ACE inhibition.
m976150 Association of the Insertion/DeletionPolymorphism of the Angiotensin Converting
Enzyme Gene and Angiotensin Converting
Enzyme inhibitor Cough in Patients with
Congestive Hesrl Fsilura
D.M. Bell, D.R. Rutledge, C.J. Pepine. Univemify of F/o~dat Gainesville, FL,
USA
Cough limits therapy with angiotensin converting enzyme inhibitor (ACE-1)
in heart failure patients. The precise mechanism is unknown, but may be
due to lower concentrations of neutral peptidaaes in the airways. Persons
homozygous for the D,variant (DD) of the ACE gene, have been shown to
have twice the serum ACE activity detaeted in persons homozygous for I (Ii).
Increased ACE activity may be a compensatory mechanism for decreased
neutral peptidaees. We hypothesize that heart failure patients with the DD
genotype are more susceptible to ACE-1cough compared with patients with
the II genotype. PCR was used to identify the polymorphism. Interviews
were used to assess individual patient reporta of ACE-1induced cough. All
patients had ejection fractions 30% and were receiving an ACE-1for greater
than 6 months. Patients complaining of a productive cough, and those with
pulmonary edema or infection were excluded. Patients who described their
cough as mild, dry, similar to “clearing the throat”, or having a “tickling
aeneetion” were categorized with ACE-1induced cough. Patients with the DD
genotype had a higher incidence of ACE-I cough compared with patients with
the DI or the II genotype (X2 = 7.7, p <“0.025). Women patients complained
of ACE-1cough more frequently than did men (38% vs. 219’., respectively;X2
= 4.63, p < 0.05). The frequency of the DD genotype was higher in women
patients compared with men (75% vs. 39Y0,X2 = 20.4, p < 0.001). Heart
failure patients with the ACE gene DD genotype appear more susceptible to
ACE-1cough compared with DI or II patients. ACE genotype may explain in
part the increased frequency of ACE-1cough reported by women patients.
1976-151 I Matrix MetaiiOprOteinaseAlterations inthe Canine
Atrium and Ventricie During Rapid Ventricular
Pscing
H.R. Parker, P.G.Scott, C.R. Bleackley, Y. Fu, D.W. O’Brien, J.E. Mitchell,
P.W.Armstrong. University of Alberta, Edmonton, Alberta, Canada
Rapid canine ventricular pacing produces remarkable cardiac structural re-
modeling reaulting in atrial but not ventricularhypertrophy. We evaluated
by zymography the role of matrix metalloproteinases (MMPs) in 24 dogs; 9
controls, 8 paced 1 week, and 7 paced 3 weeka. Hypertrophy was assesaed
by LA appendage (LAA) weight at post mortem. LV masa and LA and LV
crosa-sectional areas (CSA) were acquired by echo. Data x + SD for left
atrium (LA), left ventricle (LV) is shown in the table. This eonfirma atrial but
not ventricular hypertrophy despite similar proportionate increases in CSA.
LA hypetirophy is accompanied by elevated MMP2 activity by week 1 and
elevated presumed, ie. kDa 52, stromelysin (“MMP3”) by 3 weeks of pacing.
In contrast only MMP9 activity by the 3rd week is significantly increaaed in
the non-hypertrophied LV (*p < 0.05).
Control l-week paced 3-week paced
Heart w (!7) 19s.5 * 45 t91.9 + 32 178.6 +34.
I-M IAAlhean
CSA (cmz)
MMP2
“MMP3”
MMP9
LV mass (g)
CSA (cm2)
MMP2
“MMP3°
0.010 * 0.004
6.22 d 1.16
1.05 + 0,27
0.33 * 0.31
25.78 + 5.21
S8.91 + 12.79
14.46 & 2,29
0.63 + 0.34
0.69 + 0.41
12.66+ 1.56”
1.51 * 0.39”
0,90+ 0.56
31 .99+ 13.02
101,33 + 15.84
19.19 + 2.50”
0.92 + 0.43
1.02 + 0.36
0.020 *0.006*
15.21 + I SO*
1.30 +0,30
1.10 *0.51*
27.09 + 12,12
102.60+24,43
21.41 + 3,71*
1.00 +0.35
1.05 * 0,59
MMP?I 22.91 + 7.20 25.18 + 5.02 33.36 & 7.62*
We conclude that the differential hypertrophic response in atria vs. ventri-
cle may relate to activation of MMPs directed towards elements of basement
membrane and extracellular matrix.
m ~’eteriousActionsof Dieta~ sodium RestrictionUpon the Progression of Experimental
Congestive Heart Faiiure
D.D. Borgeson, T.L. Stevens, J.A. Grantham, A. Luchner, M.M. Redfield,
J.C. Bumeti, Jr.. Mayo Clinic Rochester MN, 55905, USA
The modulation of dieta~ sodium upon the progression of congestive heart
failure (CHF) remeins poorly defined. We tested the hypothesis that dietary
sodium restriction in contrast to excess results in premature activation of
vasoconstrictors and growth-promoting humoral factors during the progres-
sion to overt CHF. We studied the effects of low sodium (10 mEq/day, n =
6), normal sodium (55 mEq/day, n = 6), and high sodium (250 mEq/day, n
=6) diet in a consciotis canine model of tachycardia-induced CHF in which
dogswerapacedat an initialrateof 180 bpmand progressivelyincreaaedto
240 bpmto produceovertCHF. All groups demonstrated similar decreases
in MAP and CO (p < 0.05) and increases in RAP, PAP, and PCWP (p <
0.05). Dietary aodium restriction resulted in early activation of plasma renin
activity (5.2 + 1 vs 2.3 + 1.7 ng/ml/hr, p < 0.05), aldosterone (18 + 5.0 vs
2.7 + 1.2 pgfdl, p < 0.05) norepinephrine (317 + 53 vs 204 + 47 p~ml, p
< 0,05), and epinephrine (324 + 78 vs 96 + 22 pcjmi, p < 0.05) in ALVD
which persisted during progression of CHF.This early and sustained humorai
activation was associated with a greater decreaaes in ejection fraction (37.1
+ 2.9 vs 25 + 1.97., p < 0.05) despitesimilarcardiacfillingpressuresand
a decreasedleftventricularend diastolicdiameter(44.0 + 1.2 vs 49.6 + 1.3
mm p < 0.05) in overt CHF. This study demonstrates that dietary sodium
restriction accelerates activation of vasoconstrictor and mitogenic humoral
factors leading to a greater reduction in left ventricular systolic function whiie
dietary sodium excess attenuates neurohumorel activation in the during the
evolution of experimental heart failure.
D976153 Differential Regulation of Cardiac Angiotensin
Converting Enzyms (ACE) Binding Sites snd AT1
Receptor Density in Primsry Pulmonsry
Hypertension (PPH)
L. S..Zisman, K. Asano, D.L. Dutcher, M.B. Perryman, M.R. Bristow. The
University of Colorado Health Sciences Centec Denvec CO, USA
Because isolated failure of the right ventricle (RV) occurs in PPH we tested
the hypothesis that ACE binding sites would be increased and angiotensin
II receptors (ATRa) decreasad only in the RV of PPH hearts. Wa used
3H-remiprilat to quantify ACE binding sites and saralasin (12sl-[Sart, lle8]-
Ang H) to measure ATR densityin left and rightventriclesof PPH hearts
